`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD.
`Patent Owner
`
`
`
`Case No. IPR2017-001901
`Patent No. 7,214,506
`
`
`
`
`PETITIONER’S UPDATED NOTICE OF COUNSEL
`UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`1 Case IPR2017-01429 has been joined with the instant proceeding.
`
`
`
`In view of the granting of Acrux DDS Pty Ltd. and Acrux Ltd.’s (“Acrux”)
`
`Unopposed Motion for Pro Hac Vice Admission of Lisa N. Phillips on September
`
`27, 2017 (Paper No. 34) and Argentum Pharmaceuticals LLC’s (“Argentum”)
`
`Motion for Joinder on November 13, 2017 (Paper No. 40), and pursuant to 37
`
`C.F.R. § 42.8, Acrux and Argentum (collectively, “Petitioner”), hereby submits
`
`updated counsel information, adding Ms. Phillips, counsel for Acrux and Ms. Terry
`
`Rea, Ms. Shannon Lentz, and Mr. Tyler Liu, counsel for Argentum, as additional
`
`back-up counsel.
`
`Lead Counsel
`
`E. Anthony Figg (Reg. No. 27,195)
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.,
`607 14th Street, N.W., Suite 800,
`Washington, DC 20005
`Telephone: 202-783-6040
`Facsimile: 202-783-6031
`efigg@rothwellfigg.com
`
`Back-Up Counsel
`
`Aydin H. Harston
`(Reg. No. 65,249)
`Rothwell, Figg, Ernst & Manbeck, P.C.,
`607 14th Street, N.W., Suite 800,
`Washington, DC 20005
`Telephone: 202-783-6040
`Facsimile: 202-783-6031
`aharston@rothwellfigg.com
`
`Lisa N. Phillips
`(admitted pro hac vice)
`Rothwell, Figg, Ernst & Manbeck, P.C.,
`607 14th Street, N.W., Suite 800,
`Washington, DC 20005
`Telephone: 202-783-6040
`Facsimile: 202-783-6031
`lphillips@rothwellfigg.com
`
`
`
`Teresa Stanek Rea
`Reg. No. 30,427
`Crowell & Moring LLP
`1001 Pennsylvania Ave NW
`Washington, DC 20004
`(202) 624-2620
`TRea@Crowell.com
`
`
`Shannon M. Lentz
`Reg. No. 65,382
`Crowell & Moring LLP
`1001 Pennsylvania Ave NW
`Washington, DC 20004
`(202) 624-2897
`SLentz@Crowell.com
`
`Tyler C. Liu
`Reg. No. 72,126
`Argentum
`Pharmaceuticals,
`LLC
`(202) 749-8605
`TLiu@agpharm.com
`
`Petitioners consent to service by email at:
`
`efigg@rothwellfigg.com;
`
`aharston@rothwellfigg.com;
`
`lphillips@rothwellfigg.com;
`
`litigationparalegals@rothwellfigg.com;
`
`trea@crowell.com;
`
`slentz@crowell.com; and
`
`tliu@agpharm.com.
`
`
`
`Date: November 27, 2017
`
`
`
`
`Respectfully submitted,
`
`By: __/s/ Aydin H. Harston_________
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST &
`MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`
`Counsel for Petitioners Acrux
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that the foregoing document entitled
`
`PETITIONER’S UPDATED NOTICE OF COUNSEL UNDER 37 C.F.R. § 42.8
`
`was served electronically via email on November 27, 2017 to Patent Owner’s
`
`counsel of record and counsel of record for Petitioner Argentum, at the following:
`
`Patent Owner
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`naoki.yoshida@finnegan.com
`anthony.hartmann@finnegan.com
`toan.vo@bausch.com
`
`
`
`
`
`Date: November 27, 2017
`
`
`Petitioner Argentum
`trea@crowell.com
`slentz@crowell.com
`tliu@agpharm.com
`
`
`
`
`Respectfully submitted,
`
`By: __/s/ Aydin H. Harston_________
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST &
`MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`
`
`
`
`
`
`
`